Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aakaar Medical TechnologiesNSE:AAKAAR -4.94%20 PS Ratio is 1.43 as of Jul. 25, 2026, which is 12% below its 10-year median of 1.63. GuruFocus rates NSE:AAKAAR with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Aakaar Medical Technologies ranks better than 68.28% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aakaar Medical Technologies's share price is ₹71.20.
Aakaar Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹49.77. Hence, Aakaar Medical Technologies's PS Ratio for today is 1.43.
The historical rank and industry rank for Aakaar Medical Technologies's PS Ratio or its related term are showing as below:
NSE:AAKAAR'
s PS Ratio Range Over the Past 10 Years
Min: 1.03 Med: 1.63 Max: 2.21
Current: 1.44
During the past 5 years, Aakaar Medical Technologies's highest PS Ratio was 2.21. The lowest was 1.03. And the median was 1.63.
NSE:AAKAAR's PS Ratio is ranked better than 68.28% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.83
vs NSE:AAKAAR: 1.44
During the past 5 years, Aakaar Medical Technologies's highest 3-Year average Revenue per Share Growth Rate was 47.00% per year. The lowest was 29.90% per year. And the median was 38.45% per year.
Back to Basics: PS Ratio
Aakaar Medical Technologies (NSE:AAKAAR) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Aakaar Medical Technologies PS Ratio Related Terms
Aakaar Medical Technologies PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Aakaar Medical Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aakaar Medical Technologies PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aakaar Medical Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Aakaar Medical Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Aakaar Medical Technologies's Share Price of today is ₹71.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aakaar Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹49.77.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Aakaar Medical Technologies (NSE:AAKAAR) has a PS Ratio of 1.43 as of Jul. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aakaar Medical Technologies and its competitors. This is 12% below median its historical median of 1.63. Over the past decade, Aakaar Medical Technologies' PS Ratio has ranged from 1.03 to 2.21. According to the industry distribution chart, Aakaar Medical Technologies ranks #255 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 31.7%.
Is Aakaar Medical Technologies' PS Ratio too high?
Aakaar Medical Technologies' current PS Ratio of 1.43 is 12% below median its 10-year median of 1.63. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 2.21. The Medical Devices & Instruments industry median PS Ratio is 2.83. Aakaar Medical Technologies' value of 1.43 is 49.5% below this industry median. Based on the distribution chart, Aakaar Medical Technologies ranks #255 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aakaar Medical Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aakaar Medical Technologies ranks #255 out of 804 companies for PS Ratio. This puts Aakaar Medical Technologies in the upper half of its industry. The industry median PS Ratio is 2.83. Aakaar Medical Technologies' value of 1.43 is 49.5% below this benchmark. Historically, Aakaar Medical Technologies' own PS Ratio has ranged from 1.03 to 2.21 over the past decade. While the company's 10-year median is 1.63 vs. the industry median of 2.83, Aakaar Medical Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.83, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aakaar Medical Technologies's current PS Ratio of 1.43 is 49.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aakaar Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aakaar Medical Technologies's current PS Ratio is 1.43, which is 12% below median its own 10-year median of 1.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current PS Ratio of 1.43. The current PS Ratio is 1.43, which is 12% below median its 10-year median of 1.63 and 49.5% below the Medical Devices & Instruments industry median of 2.83. Aakaar Medical Technologies' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current PS Ratio is 1.43 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
20GF Score
Get the complete analysis for NSE:AAKAAR
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AAKAAR has been successfully added to your 
